{
    "nctId": "NCT01199393",
    "briefTitle": "Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer",
    "officialTitle": "Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasm, Drug Therapy, Polymorphism,Single Nucleotide",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 153,
    "primaryOutcomeMeasure": "Response to chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed metastatic breast cancer\n* Female\n* An Eastern Cooperative Oncology Group (ECOG) performance status of 0-2\n* At least one measurable lesion\n* Normal cardiac, hepatic, renal and bone marrow functions\n* Life expectancy \u22653 months\n* Discontinuity of previous chemotherapy for a minimum of 4 weeks\n\nExclusion Criteria:\n\n* Central nervous system metastases\n* Serious or uncontrolled concurrent medical illness\n* History of other malignancies",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}